Gilead Sciences (GILD) Shares Outstanding (2009 - 2026)

Gilead Sciences has reported Shares Outstanding for 18 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.24% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (changed 0.24% YoY), and the FY2025 full-year result was $1.2 billion, changed 0.4% from the prior year.
• Shares Outstanding for Q1 2026 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
• The five-year high for Shares Outstanding was $1.3 billion in Q1 2022, with the low at $1.2 billion in Q4 2025.
• Historically, Shares Outstanding has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2023.
• The largest YoY upside for Shares Outstanding was 0.08% in 2022 against a maximum downside of 0.56% in 2022.
• Gilead Sciences' Shares Outstanding stood at $1.2 billion in 2022, then dropped by 0.08% to $1.2 billion in 2023, then changed by 0.0% to $1.2 billion in 2024, then retreated by 0.4% to $1.2 billion in 2025, then rose by 0.08% to $1.2 billion in 2026.
• The last three Shares Outstanding figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.